News

Interview with Dr. Anneke Hesseling – Part One

Dr. Anneke Hesseling is the Director of the Paediatric TB Research Program at the Desmond Tutu TB Centre at Stellenbosch University in Cape Town, South Africa. She has South African and US training in Medicine and Epidemiology and is the PI and co-PI on several large research projects relates to the epidemiology, transmission and diagnosis of tuberculosis in children, with special emphasis on the interaction between pediatric TB and HIV and the immunologic diagnosis of TB infection and disease. Dr. Hesseling has a special research interest in the epidemiologic and immunologic interaction between BCG and HIV in children and is the chairperson of the IUATLD BCG Working Group.

An interview with Dr. Hesseling from the 41st Union World Conference on Lung Health in Berlin can be found on the Science Speaks blog here.

More News
30 Mar 2021
Médecins Sans Frontières (MSF) published a press release on World TB Day 2021 announcing their clinical trial, TB-Practecal , investigating novel treatment for MDR-TB has stopped enrolling earlier than originally planned due to promising results. The trial's independent data safety and monitoring...
3 Feb 2021
Last week, the World Health Organization (WHO) held a consultation to discuss the definition of extensively drug resistant (XDR) tuberculosis. The meeting was held to discuss novel treatment regimens and diagnostics for drug-resistant TB and determine its impact on the definition of XDR-TB. The...
10 Dec 2020
The Stop TB Partnership Working Group on New TB Vaccines (WGNV), Working Group on New TB Drugs (WGND), and New Diagnostics Working Group (NDWG) are developing an online course specifically designed for advocates and affected communities to provide a base of knowledge in TB research and to generate...